Bridgewater Associates - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$26,367,240
-5.3%
698,655
+14.4%
0.16%
-7.6%
Q2 2023$27,835,884
-3.6%
610,972
-14.1%
0.17%
-2.3%
Q1 2023$28,864,930
-24.6%
711,660
-5.3%
0.18%
-15.8%
Q4 2022$38,298,042
-24.4%
751,384
-20.1%
0.21%
-18.4%
Q3 2022$50,636,000
-9.1%
940,150
+8.4%
0.26%
+8.5%
Q2 2022$55,726,000
-24.3%
867,608
-8.6%
0.24%
-20.5%
Q1 2022$73,567,000
+31.2%
948,766
+45.3%
0.30%
-8.9%
Q4 2021$56,067,000
+23.1%
653,161
+15.3%
0.33%
+30.9%
Q3 2021$45,545,000
-3.0%
566,263
-3.0%
0.25%
-17.3%
Q2 2021$46,975,000
+59.0%
583,535
+66.5%
0.30%
+15.3%
Q1 2021$29,552,000
+36.9%
350,395
+30.3%
0.26%
+39.6%
Q4 2020$21,584,000
+115.2%
268,996
+115.7%
0.19%
+54.5%
Q3 2020$10,028,000
+643.9%
124,701
+650.9%
0.12%
+348.1%
Q1 2020$1,348,000
-26.9%
16,606
-34.0%
0.03%
+80.0%
Q4 2014$1,844,000
+39.2%
25,163
+36.3%
0.02%
+50.0%
Q3 2014$1,325,000
+217.7%
18,463
+220.4%
0.01%
+233.3%
Q2 2014$417,000
-90.9%
5,763
-90.7%
0.00%
-91.9%
Q1 2014$4,581,000
-65.1%
62,263
-67.0%
0.04%
-64.8%
Q4 2013$13,122,000
-20.4%
188,663
-24.9%
0.10%
-24.5%
Q3 2013$16,492,000
+317.1%
251,063
+339.8%
0.14%
+297.1%
Q2 2013$3,954,00057,0800.04%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders